[1]
M. S. Firstenberg, “Safety and Efficacy of Cangrelor, an Intravenous, Short-Acting Platelet Inhibitor in Patients Requiring Coronary Artery Bypass Surgery”, HSF, vol. 16, no. 2, pp. E60-E69, Apr. 2015.